inclusion criteria: * covid-19 positive patients with ordinal scale score of 3. * patients of either gender, age ≥ 18 years at the time of enrollment. * female patients who are currently using reliable methods of contraception (barrier methods and intrauterine contraceptive device), with a negative urine pregnancy test during screening and agree to informed compliance of contraceptive method until at least 3 months post-dosing. * the patients must be able and willing to comply with the study protocol, available and willing to complete all the study assessments and must have signed an informed consent form.

inclusion criteria: * covid-19 positive patients with ordinal scale score of 3. * patients of either gender, age ≥ 18 years at the time of enrollment. * female patients who are currently using reliable methods of contraception (barrier methods and intrauterine contraceptive device), with a negative urine pregnancy test during screening and agree to informed compliance of contraceptive method until at least 3 months post-dosing. * the patients must be able and willing to comply with the study protocol, available and willing to complete all the study assessments and must have signed an informed consent form.

inclusion criteria: - covid-19 positive patients with ordinal scale score of 3. - patients of either gender, age ≥ 18 years at the time of enrollment. - female patients who are currently using reliable methods of contraception (barrier methods and intrauterine contraceptive device), with a negative urine pregnancy test during screening and agree to informed compliance of contraceptive method until at least 3 months post-dosing. - the patients must be able and willing to comply with the study protocol, available and willing to complete all the study assessments and must have signed an informed consent form.

inclusion criteria: - covid-19 positive patients with ordinal scale score of 3. - patients of either gender, age ≥ 18 years at the time of enrollment. - female patients who are currently using reliable methods of contraception (barrier methods and intrauterine contraceptive device), with a negative urine pregnancy test during screening and agree to informed compliance of contraceptive method until at least 3 months post-dosing. - the patients must be able and willing to comply with the study protocol, available and willing to complete all the study assessments and must have signed an informed consent form.